The increase in IL6 signaling observed in T1D patients (26, 27) modulates immune response through the expansion of pathogenic Th17 cells and inhibition of generation of Foxp3 + T-regulatory cells is associated with T1D autoimmunity (28–30). The gene discussed is FOXP3; the disease is Autoimmunity.